PCMC
ABBV icon

Planning Capital Management Corporation’s AbbVie ABBV Stock Holding History

Planning Capital Management Corporation’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$45.7K Sell
231
-536
-70% -$100K 0.03% 191
2024
Q2 		$132K Sell
767
-21
-3% -$3.48K 0.09% 118
2024
Q1 		$143K Sell
788
-115
-13% -$19.8K 0.1% 105
2023
Q4 		$140K Buy
+903
New +$132K 0.11% 106

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Planning Capital Management Corporation's ABBV Position: Q3 2024 in Review

Planning Capital Management Corporation reduced its AbbVie (ABBV) stake by 70% in Q3 2024, selling an estimated $100K and leaving 231 shares worth $45.7K. The position accounts for 0.03% of the portfolio, ranked #191.

Planning Capital Management Corporation first reported a position in ABBV in Q4 2023 and has held it in 4 quarters since. The position peaked at $143K in Q1 2024. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Planning Capital Management Corporation held 231 shares of AbbVie worth $45.7K as of Q3 2024.
  • Planning Capital Management Corporation sold 536 AbbVie shares in Q3 2024, an estimated $100K.
  • AbbVie made up 0.03% of Planning Capital Management Corporation's portfolio in Q3 2024, its #191 holding.
  • Planning Capital Management Corporation first reported a position in AbbVie in Q4 2023 and has held it in 4 quarters since.
  • Planning Capital Management Corporation's AbbVie position peaked at $143K in Q1 2024.
  • 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.